Mesa Laboratories, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $60.1M | $63.7M | $65.1M | $60.7M | $59.5M | $62.1M | $62.8M | $57.8M |
| Cost of Revenue | $21.1M | $21.5M | $23.3M | $23.4M | $22.6M | $23.7M | $23.1M | $22.4M |
| Gross Profit | $39.0M | $42.2M | $41.8M | $37.3M | $36.9M | $38.4M | $39.8M | $35.5M |
| Gross Margin | 64.9% | 66.2% | 64.2% | 61.5% | 62.0% | 61.8% | 63.3% | 61.3% |
| Operating Expenses | ||||||||
| Research & Development | $4.7M | $5.2M | $5.0M | $5.0M | $5.0M | $5.1M | $5.1M | $4.6M |
| SG&A Expense | $17.4M | $24.1M | $18.8M | $17.8M | $18.0M | $20.6M | $18.5M | $17.5M |
| Operating Income | $7.0M | $2.7M | $8.0M | $4.7M | $3.1M | $1.5M | $5.8M | $3.5M |
| Operating Margin | 11.7% | 4.3% | 12.2% | 7.8% | 5.1% | 2.4% | 9.2% | 6.1% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $4.4M | $-1.6M | $4.6M | $2.0M | $7.0M | $461.0K | $-2.2M | $3.8M |
| Income Tax Expense | $1.5M | $2.5M | $966.0K | $-477.0K | $2.3M | $7.6M | $-541.0K | $384.0K |
| Net Income | $2.8M | $-4.1M | $3.6M | $2.5M | $4.7M | $-7.1M | $-1.7M | $3.4M |
| Net Margin | 4.7% | -6.5% | 5.6% | 4.1% | 8.0% | -11.4% | -2.7% | 5.9% |
| EPS (Basic) | $0.50 | $-0.76 | $0.66 | $0.45 | $0.87 | $-1.31 | $-0.31 | $0.63 |
| EPS (Diluted) | $0.49 | $-0.74 | $0.65 | $0.45 | $0.85 | $-1.30 | $-0.31 | $0.63 |
| Shares Outstanding (Basic) | 5.7M | 5.5M | 5.5M | 5.5M | 5.5M | 5.4M | 5.4M | 5.4M |
| Shares Outstanding (Diluted) | 5.8M | 5.6M | 5.6M | 5.5M | 5.6M | 5.4M | 5.4M | 5.5M |
| Dividends Per Share | $0.16 | $0.16 | $0.16 | $0.16 | $0.16 | $0.16 | $0.16 | $0.16 |